: close

Investor Center

Shareholders Meeting

Financial Data

Financial Statements

Analysts Meeting Materials

TSE Filings

Mar. 18, 2019: Taiyo Nippon Sanso Corporation Announces
“Notice Regarding Financing through a Subordinated Loan”

Mar. 01, 2019: Notice Regarding Completed Acquisition of a HyCO Business and Related Assets
in the United States

Feb. 25, 2019: Notice Regarding Changes in Representative Corporate Executive Officers

Feb. 20, 2019: Mitsubishi Tanabe Pharma Corporation Received Notice of Request for Arbitration

Feb. 06, 2019: Consolidated Financial Information for the Third Quarter of the Fiscal Year Ending March 31, 2019

Find out more

IR News

Dec. 04, 2018: APTSIS 20 Current Status

Jun. 27, 2018: Voting Results of the 13th Ordinary General Meeting of Shareholders

Jun. 26, 2018: Notice of the Resolutions Adopted at the 13th Ordinary General Meeting of Shareholders

Jun. 26, 2018: (Revision) Partial Revision to the “Condensed Consolidated Financial Information
for the Fiscal Year Ended March 31, 2018”

Jun. 12, 2018: Establishment of the MCHC Disclosure Policy

Find out more

IR Calendar

IR Calendar

Find out more

Medium-Term
Management Plan

Our medium-term management plan,
APTSIS 20 (for fiscal years 2016-2020)
- Find out more
IR Library
Stock and Bond
Information
Financial Data
- Financial Highlight
- Historical DATA

To Our Individual Investors

To Our Individual Investors

Hitoshi Ochi,Representative Corporate Executive Officer,President & CEO — Hitoshi Ochi,
Representative Corporate Executive Officer,
President & CEO

Hitoshi Ochi,Representative Corporate Executive Officer,President & CEO — Hitoshi Ochi,
Representative Corporate Executive Officer,
President & CEO

Latest IR Materials

Our latest financial results announcement, operating summary, and APTSIS 20 current status can be downloaded.

Contents

Operating Summary of 3Q-FY2018 (Feb. 2019)
Financial Results Announcement of 3Q-FY2018 (Feb. 2019)
APTSIS20 Current Status (Dec.2018)

Sitemap